Differentiated care to help Peruvian adolescents transition to adult HIV care
Efficacy of a differentiated care intervention for adolescents transitioning to adult HIV care in Peru
This project compares two lengths of a community-based, tailored support program for adolescents with HIV in Lima, Peru who are moving from pediatric to adult care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11125929 on NIH RePORTER |
What this research studies
If you join, you would receive community-based support that addresses urgent needs (like housing), helps navigate insurance and clinic transfers, accompanies you to adult clinic appointments, runs peer support and skills-building sessions, and screens for mental health. The amount and length of support (approximately 6 or 12 months) will be matched to your needs such as adherence, viral load suppression, family support, and transition readiness. The team builds on a local community-health platform and a pilot of 30 adolescents that showed the approach was acceptable and promising. The project will track health outcomes, costs, and how the program can be carried out in real-world clinics.
Who could benefit from this research
Good fit: Adolescents and young people living with HIV in Lima, Peru who are preparing to move from pediatric to adult HIV care (late teens/young adults) are the ideal candidates.
Not a fit: People who are already established in adult HIV care, live far outside Lima, or do not need transition support are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could help more adolescents stay on treatment, improve adherence and viral suppression, and make the move to adult HIV care smoother and safer.
How similar studies have performed: A prior pilot of 30 adolescents in Peru showed strong acceptability and positive signals for adherence, social support, self-efficacy, and transition readiness, but larger trials are still needed.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Franke, Molly Forrest — Harvard Medical School
- Study coordinator: Franke, Molly Forrest
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.